[go: up one dir, main page]

NL194463C - Farmaceutisch preparaat dat 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H- imidazool-1-yl)methyl]-4H-carbazool-4-on bevat. - Google Patents

Farmaceutisch preparaat dat 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H- imidazool-1-yl)methyl]-4H-carbazool-4-on bevat. Download PDF

Info

Publication number
NL194463C
NL194463C NL8900526A NL8900526A NL194463C NL 194463 C NL194463 C NL 194463C NL 8900526 A NL8900526 A NL 8900526A NL 8900526 A NL8900526 A NL 8900526A NL 194463 C NL194463 C NL 194463C
Authority
NL
Netherlands
Prior art keywords
methyl
tetrahydro
imidazol
carbazole
dexamethasone
Prior art date
Application number
NL8900526A
Other languages
English (en)
Dutch (nl)
Other versions
NL194463B (nl
NL8900526A (nl
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10632894&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL194463(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8900526A publication Critical patent/NL8900526A/nl
Publication of NL194463B publication Critical patent/NL194463B/xx
Application granted granted Critical
Publication of NL194463C publication Critical patent/NL194463C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8900526A 1988-03-04 1989-03-03 Farmaceutisch preparaat dat 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H- imidazool-1-yl)methyl]-4H-carbazool-4-on bevat. NL194463C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8805269 1988-03-04
GB888805269A GB8805269D0 (en) 1988-03-04 1988-03-04 Medicaments

Publications (3)

Publication Number Publication Date
NL8900526A NL8900526A (nl) 1989-10-02
NL194463B NL194463B (nl) 2002-01-02
NL194463C true NL194463C (nl) 2002-05-03

Family

ID=10632894

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8900526A NL194463C (nl) 1988-03-04 1989-03-03 Farmaceutisch preparaat dat 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H- imidazool-1-yl)methyl]-4H-carbazool-4-on bevat.

Country Status (23)

Country Link
US (2) US6544550B1 (de)
JP (1) JPH0296525A (de)
KR (1) KR890014109A (de)
AT (1) AT400301B (de)
AU (1) AU626010B2 (de)
BE (1) BE1002255A5 (de)
CA (1) CA1319323C (de)
CH (1) CH678149A5 (de)
CY (1) CY1634A (de)
CZ (1) CZ402391A3 (de)
DE (1) DE3906883C2 (de)
DK (1) DK175428B1 (de)
FR (1) FR2627986B1 (de)
GB (2) GB8805269D0 (de)
HK (1) HK41792A (de)
IE (1) IE61516B1 (de)
IT (1) IT1232662B (de)
NL (1) NL194463C (de)
NZ (1) NZ228214A (de)
SE (1) SE508342C2 (de)
SG (1) SG9092G (de)
SK (1) SK402391A3 (de)
ZA (1) ZA891639B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929059A (en) * 1991-01-19 1999-07-27 Smithkline Beecham P.L.C. Pharmaceutical compositions containing granisetron and dexamethasone
GB9101221D0 (en) * 1991-01-19 1991-02-27 Smithkline Beecham Plc Pharmaceuticals
DK0533280T4 (da) * 1991-09-20 2005-02-28 Glaxo Group Ltd Ny medicinsk anvendelse af tachykininantagonister
JPH08507514A (ja) * 1993-03-08 1996-08-13 藤沢薬品工業株式会社 脳血管性疾患を治療または予防するための薬物
US5661142A (en) * 1996-04-17 1997-08-26 Naeger; David M. Anti-emetic composition
WO2005108392A2 (en) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20050277624A1 (en) * 2004-06-09 2005-12-15 Nigel Cook Use of corticosteroids alone or in conjunction with nutritional therapy to reduce stress in animals
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19375046I2 (de) * 1984-01-25 2002-10-10 Glaxo Group Ltd 1,2,3,9-Tetrahydro-3-Ä(1H-imidazol-1-yl)methylÜ-4H-carbazol-4-one Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
EP0191562B1 (de) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolonderivate
EP0201165B1 (de) * 1985-03-14 1994-07-20 Beecham Group Plc Arzneimittel zur Behandlung von Emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
IL84845A0 (en) * 1986-12-17 1988-06-30 Glaxo Group Ltd Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
US4920219A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
US5246709A (en) * 1990-09-10 1993-09-21 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
IE890697L (en) 1989-09-04
NZ228214A (en) 1997-02-24
DK104389A (da) 1989-09-05
FR2627986A1 (fr) 1989-09-08
HK41792A (en) 1992-06-19
ZA891639B (en) 1990-03-28
KR890014109A (ko) 1989-10-21
NL194463B (nl) 2002-01-02
US5482716A (en) 1996-01-09
JPH0296525A (ja) 1990-04-09
SE8900751D0 (sv) 1989-03-03
GB8904881D0 (en) 1989-04-12
BE1002255A5 (fr) 1990-11-06
CH678149A5 (de) 1991-08-15
IT1232662B (it) 1992-03-02
GB2216414B (en) 1991-12-11
CZ402391A3 (en) 1993-04-14
CA1319323C (en) 1993-06-22
DK104389D0 (da) 1989-03-03
AU626010B2 (en) 1992-07-23
US6544550B1 (en) 2003-04-08
ATA48389A (de) 1995-04-15
DK175428B1 (da) 2004-10-18
SE508342C2 (sv) 1998-09-28
SK402391A3 (en) 2000-12-11
IE61516B1 (en) 1994-11-16
GB2216414A (en) 1989-10-11
DE3906883A1 (de) 1989-09-14
DE3906883C2 (de) 1998-11-05
FR2627986B1 (fr) 1994-03-04
NL8900526A (nl) 1989-10-02
SG9092G (en) 1992-03-20
IT8947713A0 (it) 1989-03-03
AT400301B (de) 1995-12-27
CY1634A (en) 1992-11-06
AU3097689A (en) 1989-09-07
SE8900751L (sv) 1989-09-05
GB8805269D0 (en) 1988-04-07

Similar Documents

Publication Publication Date Title
US4929632A (en) Medicaments
US5578632A (en) Medicaments for the treatment of gastrointestinal dysfunction
NL194463C (nl) Farmaceutisch preparaat dat 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H- imidazool-1-yl)methyl]-4H-carbazool-4-on bevat.
CA1330306C (en) Medicament for the treatment and prevention of nausea and vomiting
JP2834175B2 (ja) 医 薬
US5240954A (en) Medicaments
CA2100777C (en) Pharmaceutical composition containing granisetron and dexamethasone
JPS63211227A (ja) 医薬
US4018924A (en) Phenyl-imidazolyl-acetamide derivatives
NL8802906A (nl) Geneesmiddel.
JPS5929672A (ja) 置換ヘテロサイクリルフエニルスルホニルおよびホスホニルアミジン化合物

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20090303